| Archived Events |
|---|
EULAR 2009: TRU-015 Retreatment Data Presentation
Jun 11, 2009
Speaker: Scott Stromatt, Chief Medical Officer, Trubion
|
|
|
8th Annual Needham Life Sciences Conference
Jun 10, 2009 2:00 PM ET
|
|
Dr. Ken Mohler, co-founder and Senior Vice President of research and development, and Michelle Burris, Senior Vice President and Chief Financial Officer, are scheduled to present.
|
Three TRU-016 Presentations Accepted for Presentation at the 2009 ASCO Annual Meeting
May 31, 2009
|
|
TRU-016 Phase 1 ASCO 2009 Poster
289.5 KB PDF
TRU-016 ASCO 2009 NHL Poster.pdf
1.5 MB PDF
TRU-016 ASCO-2009 Apoptosis Poster 3035.pdf
579.4 KB PDF
Orlando, FL
Phase 1: Encouraging Results Observed in CLL Patients Treated With Low Doses of TRU-016
Preclinical Efficacy: TRU-016 is Additive or Synergistic in Combination with Established Therapeutics
Preclinical Mechanism Apoptosis in CLL Cells Occurs Via Distinct Mechanism Compared With Other Therapeutics
Complete abstracts are available on ASCO's web site at:
http://www.asco.org/ASCOv2/Meetings/ASCO+Annual+Meeting
|
Trubion First Quarter 2009 Earnings Conference Call
May 7, 2009 2:00 PM PT
|
|
|
Trubion Presents SCORPION Data at 2009 AACR Annual Meeting
Apr 22, 2009 8:00 AM -
12:00 PM
Speaker: John W. Blankenship
|
|
2.4 MB PDF
Preclinical Poster Presentation: "CD79BxDR SCORPION molecule -a single chain, bispecific immunotherapeutic with potent in vitro activity against B cell lymphoma"
|
Invest Northwest Investor Conference
Mar 18, 2009
Speaker: Michelle Burris, CFO and SVP, Trubion
|
|
Bell Harbor Convention Center
Seattle
|
Trubion Fourth Quarter and Year-End 2008 Earnings Conference Call
Mar 12, 2009 2:00 PM PT
|
|
|
BIO CEO & Investor Conference
Feb 10, 2009
Speaker: Peter Thompson, MD, FACP, CEO and Chairman, Trubion
|
|
|
Lazard Capital Management 5th Annual Investor Healthcare Conference
Nov 18, 2008
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
|
Trubion Third Quarter 2008 Earnings Conference Call
Nov 10, 2008 2:00 PM PT
|
|
|
Rodman & Renshaw 10th Annual Investor Healthcare Conference
Nov 10, 2008 -
Nov 12, 2008
Speaker: Michelle Burris, CFO, SVP
|
|
|
ACR 2008 Annual Meeting
Oct 26, 2008 9:00 AM -
11:00 AM PT
|
|
1.2 MB PDF
Presentation: 374 - TRU-015 Administered Every 24 Weeks for 2 Years is Well Tolerated and Maintains Consistent Pharmacodynamic Effects in Rheumatoid Arthritis Patients
http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2173&sKey=dce5e7b7-ccd3-441c-97b8-23a76a10390d&cKey=966b267e-79a4-4f45-979c-f895e78dc77c
|
2008 American College of Clinical Pharmacology Annual Meeting
Sep 14, 2008 -
Sep 16, 2008
|
|
524.3 KB PDF
TRU-015 for RA PK Data Presentation
|
Morgan Stanley Global Healthcare Unplugged Conference
Sep 9, 2008 4:30 PM ET
Speaker: Peter Thompson, MD, FACP
|
|
Grand Hyatt New York
Dr. Peter Thompson, President, Chief Executive Officer and Chairman, and Dr. Scott C. Stromatt, newly appointed Senior Vice President and Chief Medical Officer, are scheduled to present.
|
Trubion Second Quarter 2008 Earnings Conference Call
Aug 7, 2008 2:00 PM PT
|
|
|
Bank of America 2008 Specialty Pharmaceuticals Conference
Aug 7, 2008 8:45 AM ET
Speaker: Dr. Peter A. Thompson, President, CEO and Chairman
|
|
Southampton Inn
Long Island, NY
|
2008 PDA/EBE Conference on Biopharmaceutical Development and Manufacturing
Jun 24, 2008 -
Jun 25, 2008
Speaker: Vijay Yabannavar, Ph.D., VP, Process Development and Manufacturing
|
|
|
Needham 7th Annual Biotechnology & Medical Technology Conference
Jun 12, 2008 10:00 AM ET
Speaker: Ken Mohler, PhD, Co-founder, Senior Vice President of Research & Development, and Michelle Burris, Senior Vice President and Chief Financial Officer
|
|
New York Palace Hotel, NY, NY
|
Trubion Presents Positive Pre-clinical TRU-016 Data at ASCO
Jun 2, 2008
|
|
|
Bank of America 2008 Health Care Conference
May 13, 2008 1:20 PM PT
Speaker: Michelle Burris, Senior Vice President and Chief Financial Officer
|
|
The Four Seasons Hotel, Las Vegas, NV
|
Trubion First Quarter 2008 Earnings Conference Call
May 8, 2008 2:00 PM PT
|
|
|
Morgan Stanley Global Healthcare Unplugged Conference
Apr 30, 2008 9:50 AM ET
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
The Ritz-Carlton, Key Biscayne, FL
|
2008 Gene Therapy of Arthritis and Related Disorders Annual Meeting
Apr 29, 2008
Speaker: Ken Mohler, Ph.D, SVP R&D Trubion
|
|
|
Cell Culture Engineering XI Conference
Apr 13, 2008
Speaker: Vijay Yabannavar, VP, Manufacturing
|
|
|
Invest Northwest CEO & Investor Forum
Mar 18, 2008 11:20 AM PT
Speaker: Ken Mohler, PhD, Co-founder, Senior Vice President of Research & Development
|
|
Bell Harbor International Conference Center, Seattle, WA
|
Trubion Fourth Quarter 2007 Earnings Conference Call
Mar 13, 2008 2:00 PM PT
|
|
|
Sanford Bernstein Biotechnology Conference
Mar 10, 2008
Speaker: Dr. Peter Thompson, President, CEO and Chairman
|
|
|
TRU-016 ASH 2007 Presentation
Dec 8, 2007 -
Dec 11, 2007
|
|
984.1 KB PDF
Data summary:
TRU-016 induces potent ADCC against primary B-CLL cells; TRU-016 demonstrates significant in vivo therapeutic efficacy in an SCID mouse xenograft leukemia/lymphoma model; TRU-016 induces potent apoptosis in primary CLL cells
Data presented by OSU investigators at the 49th annual meeting of the American Society of Hematology (ASH). The meeting was held Dec. 8-11, 2007, at the Georgia World Congress Center in Atlanta.
Title:
[801] Role of CD37 SMIP, a Novel Engineered Small Modular Immunopharmaceutical, in the Treatment of CLL
|
2007 Lazard Capital Markets Healthcare Investor Conference
Nov 27, 2007 -
Nov 28, 2007
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
|
Trubion Third Quarter 2007 Earnings Conference Call
Nov 12, 2007 2:00 PM PT
|
|
|
Trubion ACR Conference Call
Nov 8, 2007 2:00 PM PT
|
|
|
2007 ACR Poster Presentations
Nov 8, 2007 8:00 AM -
Nov 9, 2007 5:00 PM
|
|
|
2007 UBS Global Life Sciences Investor Conference
Sep 24, 2007 8:30 AM ET
Speaker: Peter Thompson, MD, FACP, President, CEO and Chairman
|
|
|
Bank of America 37th Annual Investment Conference
Sep 17, 2007 2:00 PM PT
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
893.3 KB PDF
San Francisco
|
Trubion Conference Call
Sep 10, 2007 1:30 PM PT
|
|
|
BioCentury NewsMakers Investor Conference
Sep 6, 2007 2:30 PM ET
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
|
Trubion Second Quarter 2007 Earnings Conference Call
Aug 13, 2007 2:00 PM PT
|
|
|
Needham & Company Biotechnology & Medical Technology Investor Conference
Jun 14, 2007
Speaker: Michelle Burris, CFO
|
|
|
2007 ASCO Annual Meeting - Poster Presentation
Jun 3, 2007 8:00 AM
|
|
384.4 KB PDF
Poster Title: Depletion of Normal and Malignant B Cells with a CD37-
specific SMIP Molecule
Poster Number: G1
Abstract No: 3063
Presenter: Charles Cerveny, MS
Time: Sunday, June 3, 2007 8:00 AM - 12:00 PM
|
Bank of America Healthcare Conference
May 30, 2007
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
|
Morgan Stanley Global HC Unplugged Conference
May 2, 2007
Speaker: Peter Thompson, M.D., FACP, President, CEO and Chairman
|
|
A copy of Trubion's current presentation can be found at:
http://investors.trubion.com/
|
Investor Presentation
April 2007
|
|
|
Publication: "Targeting CD37 Lymphoid Maligancies With a Novel Engineered SMIP"
Apr 17, 2007
|
|
|
